BB Biotech Stock Forecast for 2023 - 2025 - 2030
Updated on 04/18/2024
BB Biotech Stock Forecast and Price Target
If the average 2024 price target of CHF47.70 recently set by prominent experts for BB Biotech is met, there would be a potential upside of approximately 14.25% from the last closing price in April, 2024. The high estimate is CHF47.70, and the low is CHF47.70. Even if you are not interested in BION stock, you should be aware of its competitors and their current standings.
14.25% Upside
BB Biotech Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, BB Biotech has seen a decline in its Price, from CHF16.85 to CHF0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of CHF44.49, which would mean an increase of 100.00%. Over the next seven years, experts predict that BB Biotech's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SOL Stock Forecast | Solvalor 61 | Underperform |
16
|
CHF292.00 | Buy/Sell | CHF0.00 | -100.00% |
| SMMCHA Stock Forecast | UBS ETF (CH) - SMIM | - |
0
|
CHF259.75 | Buy/Sell | CHF0.00 | -100.00% |
| IMHE Stock Forecast | Immo Helvetic | Outperform |
0
|
CHF217.00 | Buy/Sell | CHF0.00 | -100.00% |
| ZGLDEU Stock Forecast | ZKB Gold ETF | - |
0
|
2.10€k | Buy/Sell | 0.00€ | -100.00% |
| SRECHA Stock Forecast | UBS ETF (CH) - SXI Real Estate... | - |
0
|
CHF9.15 | Buy/Sell | CHF0.00 | -100.00% |
BB Biotech Revenue Forecast for 2023 - 2025 - 2030
In the last three years, BB Biotech has seen a decline in its Revenue, from CHF741.76M to CHF40.00k – a 99.99% decrease. For next year, analysts predict Revenue of CHF32.10M, which would mean an increase of 80150.00%. Over the next seven years, experts predict that BB Biotech's Revenue will grow at a rate of 289366.28%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SLICHA Stock Forecast | UBS ETF (CH) - SLI | - |
0
|
CHF190.62 | Buy/Sell | CHF0.00 | -100.00% |
| TIP10D Stock Forecast | UBS (Lux) Fund Solutions - Blo... | - |
0
|
$10.03 | Buy/Sell | $0.00 | -100.00% |
| UEFF Stock Forecast | UBS (Lux) Fund Solutions - Blo... | - |
0
|
22.67€ | Buy/Sell | 0.00€ | -100.00% |
.jpg)
BB Biotech Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, BB Biotech's Dividend per Share has decreased by 20.83%, from CHF3.60 to CHF2.85. For the next year, 1 analysts project BB Biotech's Dividend per Share to drop by 32.98%, reaching CHF1.91. By 2030, professionals believe that BB Biotech's Dividend per Share will decrease by 18.74%, reaching CHF2.32 – a concerning trend for the company.
BB Biotech EBIT Forecast for 2023 - 2025 - 2030
In the last three years, BB Biotech's EBIT has seen a drop from CHF693.99M to CHF-34.60M – a 104.99% decrease. According to 2 major analysts, BB Biotech's EBIT will fall by 285.69% in the next year, reaching CHF64.25M. Professionals believe that By 2030, BB Biotech's EBIT will fall to CHF79.68M– a 330.30% decrease from its current value.
BB Biotech EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, BB Biotech has seen a decline in its EPS, from CHF12.48 to CHF0.00 – a 100.00% decrease. For next year, analysts predict EPS of CHF0.62, which would mean an increase of 100.00%. Over the next seven years, experts predict that BB Biotech's EPS will grow at a rate of 100.00%.
.jpg)